A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test
Open Access
- 18 November 2017
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 178 (6) , 1427-1429
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline (Study 201465)
This publication has 11 references indexed in Scilit:
- Cancer nanomedicine: progress, challenges and opportunitiesNature Reviews Cancer, 2016
- A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque testBritish Journal of Dermatology, 2016
- Circulating T-helper 17 cells and associated cytokines in psoriasisClinical and Experimental Dermatology, 2016
- The Pitfalls of Growing NanomaterialsNanomedicine, 2016
- Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to SkinPLOS ONE, 2016
- NANOSCALE DRUG DELIVERY TECHNOLOGIES: INTRODUCTION AND RECENT DEVELOPMENTSJournal of Pharmaceutical & Scientific Innovation, 2013
- Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their ExpansionImmunity, 2012
- The emerging nanomedicine landscapeNature Biotechnology, 2006
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- RORγt, a Novel Isoform of an Orphan Receptor, Negatively Regulates Fas Ligand Expression and IL-2 Production in T CellsImmunity, 1998